| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1022612753 |
| P356 | DOI | 10.2165/00003495-200262020-00004 |
| P698 | PubMed publication ID | 11817974 |
| P2093 | author name string | Steven J Lavine | |
| Steven D Gellman | |||
| P2860 | cites work | Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 |
| Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators | Q28144781 | ||
| A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees | Q28238373 | ||
| Natriuretic peptide system in human heart failure | Q28261612 | ||
| A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure | Q28328342 | ||
| Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II | Q28369144 | ||
| The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
| Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) | Q28378044 | ||
| Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group | Q29617736 | ||
| Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group | Q29619460 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group | Q33157410 | ||
| AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions | Q33669546 | ||
| Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study | Q70746802 | ||
| Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus | Q70880904 | ||
| Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy | Q71021087 | ||
| Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure | Q71102820 | ||
| Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart | Q71102878 | ||
| Capillary microaneurysms in the human diabetic heart | Q71130234 | ||
| Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure | Q71297666 | ||
| Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus | Q71379372 | ||
| Combined renovascular hypertension and diabetes in rats: a new preparation of congestive cardiomyopathy | Q71388105 | ||
| Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group | Q71545362 | ||
| Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy | Q71745271 | ||
| Altered Ca2+ handling in ventricular myocytes isolated from diabetic rats | Q71800567 | ||
| Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure | Q71870087 | ||
| Elevation of Circulating and Ventricular Adrenomedullin in Human Congestive Heart Failure | Q71955928 | ||
| Pharmacological Study of Isoproterenol and Diabetic Cardiomyopathies in Rat Right Ventricular Strips | Q72071660 | ||
| Glucose intolerance exaggerates left ventricular hypertrophy and dysfunction in essential hypertension | Q72124577 | ||
| Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial | Q72198055 | ||
| Capillary surface area is reduced and tissue thickness from capillaries to myocytes is increased in the left ventricle of streptozotocin-diabetic rats | Q72348996 | ||
| Quantitative analysis of myocardial structure in insulin-dependent diabetes mellitus: effects of immediate and delayed insulin replacement | Q72392672 | ||
| Myocardial micronecrosis produced by microsphere embolization. Role of an alpha-adrenergic tonic influence on the coronary microcirculation | Q72570887 | ||
| Evaluation of left ventricular diastolic function in insulin dependent diabetic children by M-mode and Doppler echocardiography | Q72597089 | ||
| Altered diastolic [Ca2+]i handling in human ventricular myocytes from patients with terminal heart failure | Q72654897 | ||
| Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group | Q72659033 | ||
| Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients | Q72714167 | ||
| Heart failure in women: a special approach? | Q72773742 | ||
| Diabetic cardiomyopathy in rats: mechanical and biochemical response to different insulin doses | Q72829348 | ||
| Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II | Q72940424 | ||
| Myosin light-chain phosphorylation in diabetic cardiomyopathy in rats | Q73006819 | ||
| Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group | Q73073903 | ||
| Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes | Q73086114 | ||
| Low insulin and high glucose induce abnormal relaxation in cultured adult rat ventricular myocytes | Q73086117 | ||
| Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) | Q73164612 | ||
| Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators | Q73746095 | ||
| Rationale, design, and organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF). The International Steering Committee | Q73893393 | ||
| The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial | Q74452235 | ||
| Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure | Q74529466 | ||
| Cardiovascular risk factors as predictors of mortality in type II diabetic patients | Q74612659 | ||
| Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials | Q77319724 | ||
| Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf | Q77782556 | ||
| Ventricular expression of atrial natriuretic polypeptide and its relations with hemodynamics and histology in dilated human hearts. Immunohistochemical study of the endomyocardial biopsy specimens | Q93523678 | ||
| Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 | ||
| Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). | Q34682919 | ||
| Chronic congestive heart failure in coronary artery disease: clinical criteria | Q34729615 | ||
| Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study | Q34995225 | ||
| How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure? | Q35372794 | ||
| Coronary microvascular abnormalities in the hypertensive-diabetic rat. A primary cause of cardiomyopathy? | Q35857956 | ||
| Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human disease | Q35863637 | ||
| The myocardial renin-angiotensin system: existence, importance, and clinical implications | Q35925303 | ||
| Left ventricular function in diabetes mellitus. I: Methodology, and prevalence and spectrum of abnormalities | Q36778735 | ||
| The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence | Q37680015 | ||
| Clinical implications of hypertension in the diabetic patient | Q37929837 | ||
| Altered myocardial mechanics in diabetic rats | Q38576168 | ||
| Effect of diabetes therapy on the myocardium in experimental diabetes | Q39686311 | ||
| Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies | Q40941544 | ||
| The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM. | Q40941550 | ||
| Myocardial alterations in diabetes and hypertension | Q41158259 | ||
| Renal failure related to angiotensin-converting enzyme inhibitors. | Q41319429 | ||
| Haemodynamic studies on newly diagnosed diabetics before and after adequate insulin treatment | Q41362391 | ||
| Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials | Q41518244 | ||
| Intracellular calcium levels are unchanged in the diabetic heart | Q41526727 | ||
| Myocardial composition and function in diabetes. The effects of chronic insulin use. | Q42467375 | ||
| Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart | Q42521720 | ||
| Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group | Q42547184 | ||
| The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group | Q42556789 | ||
| Left ventricular filling abnormalities in non-insulin-dependent diabetes mellitus and improvement by a short-term glycemic control | Q43450355 | ||
| Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions | Q43472007 | ||
| The progression from hypertension to congestive heart failure | Q43812016 | ||
| The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group | Q43924876 | ||
| Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. | Q44227211 | ||
| Chronic diabetes mellitus prolongs action potential duration of rat ventricular muscles: circumstantial evidence for impaired Ca2+ channel | Q44256804 | ||
| Cardiomyopathy in childhood diabetes mellitus: incidence, time of onset, and relation to metabolic control | Q44314370 | ||
| Demonstration of restrictive ventricular physiology by Doppler echocardiography | Q44315098 | ||
| Endothelin has biological actions at pathophysiological concentrations | Q44401040 | ||
| Regulation of glomerular filtration rate in chronic congestive heart failure patients | Q44463850 | ||
| The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension | Q44611131 | ||
| Arterial baroreflex abnormalities in heart failure. Reversal after orthotopic cardiac transplantation | Q45019958 | ||
| Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study | Q45337067 | ||
| Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats | Q46906795 | ||
| Impaired left ventricular filling in young female diabetics. An echocardiographic study. | Q48555923 | ||
| Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. | Q50934595 | ||
| Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulin-dependent diabetic patients. | Q50951964 | ||
| Cellular ions in NIDDM: relation of calcium to hyperglycemia and cardiac mass. | Q51578461 | ||
| Glucose metabolism and left ventricular dysfunction are normalized by insulin and islet transplantation in mild diabetes in the rat. | Q51584250 | ||
| Adrenergic desensitization in left ventricle from streptozotocin diabetic swine. | Q51585287 | ||
| Improvement of left ventricular function after starting insulin treatment in patients with non-insulin-dependent diabetes. | Q51624566 | ||
| Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. | Q53841061 | ||
| Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (insulin-dependent) diabetic patients. | Q54103563 | ||
| Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group | Q54180877 | ||
| Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. | Q54430429 | ||
| Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension | Q57085781 | ||
| Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction | Q61918814 | ||
| Preclinical abnormality of left ventricular function in diabetes mellitus | Q66911858 | ||
| Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure | Q67391109 | ||
| Diabetes and cardiovascular risk factors: the Framingham study | Q67462912 | ||
| Myocardial function and coronary blood flow response to acute ischemia in chronic canine diabetes | Q67583505 | ||
| Left ventricular performance in diabetic patients without clinical heart disease. Evaluation by systolic time intervals and echocardiography | Q67711241 | ||
| Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy | Q68024986 | ||
| Experimental model of chronic global left ventricular dysfunction secondary to left coronary microembolization | Q68071801 | ||
| Defective response to cAMP-dependent protein kinase in non-insulin-dependent diabetic heart | Q68252836 | ||
| The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria | Q68266654 | ||
| Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography | Q68393228 | ||
| Beneficial effects of verapamil in diabetic cardiomyopathy | Q68412623 | ||
| Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure | Q68447419 | ||
| Angiotensin II-forming pathways in normal and failing human hearts | Q68452884 | ||
| Diabetic cardiomyopathy | Q68534926 | ||
| Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II) | Q68572775 | ||
| Reversibility of diabetic cardiomyopathy with insulin in rabbits | Q68858065 | ||
| Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration | Q69103973 | ||
| Contractile properties of cardiac papillary muscle in streptozotocin-diabetic rats and the effects of aldose reductase inhibition | Q69220087 | ||
| Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischemic heart disease | Q69517573 | ||
| Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure | Q69664256 | ||
| Left ventricular regional function after acute anterior myocardial infarction in diabetic patients | Q69748887 | ||
| The effect of diltiazem on mortality and reinfarction after myocardial infarction | Q69921762 | ||
| Intact systolic left ventricular function in clinical congestive heart failure | Q70081686 | ||
| Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system | Q70147707 | ||
| Correlation between histopathological changes and mechanical dysfunction in diabetic rat hearts | Q70162636 | ||
| Reversibility of diabetic cardiomyopathy with insulin in rats | Q70195592 | ||
| Prognosis of patients with diabetes mellitus after acute myocardial infarction | Q70386324 | ||
| Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis | Q70396684 | ||
| Diabetes mellitus induces changes in cardiac myosin of the rat | Q70526335 | ||
| Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (diabetic cardiomyopathy) | Q70606338 | ||
| Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy | Q70620796 | ||
| Mortality experience of diabetic patients. A twenty-six-year follow-up study | Q70626628 | ||
| P433 | issue | 2 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 285-307 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Treatment of heart failure in patients with diabetes mellitus | |
| P478 | volume | 62 |
| Q35575685 | Are β-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials |
| Q45208982 | Chronic heart failure-related interventions after starting rosiglitazone in patients receiving insulin |
| Q73782446 | Diabetic cardiomyopathy. the importance of being earliest |
| Q73668675 | Prevalence, predictors, and prognostic implications of improvement in left ventricular systolic function and clinical status in patients >70 years of age with recently diagnosed systolic heart failure |
Search more.